MN HF 1501
died on adjournmentMinnesota Rare Disease Advisory Council funding provided, and money appropriated.
Minnesota · 2025-2026 · lower
Quick answers
Did MN HF 1501 pass?
No. MN HF 1501 died when the 2025-2026 session adjourned without final action on it. Bills that die this way are sometimes reintroduced in a later session. Latest recorded action (2025-04-24): Author added Howard
What is MN HF 1501 about?
MN HF 1501 is a bill in the 2025-2026 titled “Minnesota Rare Disease Advisory Council funding provided, and money appropriated.”.
Who sponsors MN HF 1501?
Murphy is the primary sponsor of MN HF 1501, joined by 9 cosponsors.
- Introduced
- 2025-02-26
- Latest action
- 2025-04-24 — Author added Howard
- Bill type
- bill
- Last updated
- —
Subjects
Sponsors
- Murphyprimary
- Reyercosponsor
- Biermancosponsor
- Torkelsoncosponsor
- Schomackercosponsor
- Youakimcosponsor
- Zeleznikarcosponsor
- Freibergcosponsor
- Hemmingsen-Jaegercosponsor
- Howardcosponsor
Committees
Not provided by source.
Action timeline
2025-02-26
Introduction and first reading, referred to Health Finance and Policy
introduction,referral-committee
2025-03-05
Author added Youakim
2025-03-06
Author added Zeleznikar
2025-04-02
Author added Freiberg
2025-04-10
Author added Hemmingsen-Jaeger
2025-04-24
Author added Howard
Versions
- Introduction — 2025-02-25Compare
Documents
Votes
Not provided by source.
Related bills
- Companion bill: SF 2037
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:24:48.331508Z
Inspect retained evidence for changes recorded after evidence tracking began:
Session-wide evidence can include changes to other bills:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=MN&identifier=HF 1501. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.